Caveolin-1-deficient mice have increased tumor microvascular permeability, angiogenesis, and growth

被引:113
作者
Lin, Michelle I. [1 ]
Yu, Jun [1 ]
Murata, Takahisa [1 ]
Sessa, William C. [1 ]
机构
[1] Yale Univ, Sch Med, Dept Pharmacol, Vasc Biol & Transplantat Program,Boyer Ctr Mol Me, New Haven, CT 06536 USA
关键词
D O I
10.1158/0008-5472.CAN-06-4082
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Caveolin-1 (Cav-1) is a major structural protein that is essential to the formation of the organelle, caveolae. Cav-1 knockout (KO) mice were observed to be completely devoid of caveolae yet they exhibit a hyperpermeable vasculature. Given the nature of the hyperpermeable Cav-1 KO endothelium, we sought to investigate if tumors grown in Cav-1 KO mice would be leaky and grow faster. Indeed, Lewis lung carcinoma cells implanted into Cav-1 KO mice had increased tumor vascular permeability, measured by Evans blue extravasation and fibrinogen deposition compared with tumors implanted into wild-type (WT) mice. Cav-1 KO mice also had significantly higher tumor growth rates, attributable to increased tumor angiogenesis and decreased tumor cell death. Furthermore, administration of an antipermeability peptide, cavtratin, was able to correct the tumor hyperpermeability as well as attenuate the increased tumor growth. Mechanistically, endothelial cells isolated from Cav-1 KO mice exhibited increased tyrosine phosphorylation on vascular endothelial growth factor (VEGF) receptor-2 (VEGFR-2) and decreased association with the adherens junction protein, VE-cadherin. Thus, the loss of Cav-1 increases tumor permeability and growth and that may relate to enhanced VEGF signaling due to lack of Cav-1 inhibition of VEGFR-2 or decreased VE-cadherin mediated VEGFR-2 phosphorylation.
引用
收藏
页码:2849 / 2856
页数:8
相关论文
共 39 条
[1]   Akt1/protein kinase Bα is critical for ischemic and VEGF-mediated angiogenesis [J].
Ackah, E ;
Yu, J ;
Zoellner, S ;
Iwakiri, Y ;
Skurk, C ;
Shibata, R ;
Ouchi, N ;
Easton, RM ;
Galasso, G ;
Birnbaum, MJ ;
Walsh, K ;
Sessa, WC .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (08) :2119-2127
[2]   Antitumor effects of in vivo caveolin gene delivery are associated with the inhibition of the proangiogenic and vasodilatory effects of nitric oxide [J].
Brouet, A ;
DeWever, J ;
Martinive, P ;
Havaux, X ;
Bouzin, C ;
Sonveaux, P ;
Feron, O .
FASEB JOURNAL, 2004, 18 (15) :602-+
[3]   In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation [J].
Bucci, M ;
Gratton, JP ;
Rudic, RD ;
Acevedo, L ;
Roviezzo, F ;
Cirino, G ;
Sessa, WC .
NATURE MEDICINE, 2000, 6 (12) :1362-1367
[4]   Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis [J].
Carmeliet, P ;
Lampugnani, MG ;
Moons, L ;
Breviario, F ;
Compernolle, V ;
Bono, F ;
Balconi, G ;
Spagnuolo, R ;
Oosthuyse, B ;
Dewerchin, M ;
Zanetti, A ;
Angellilo, A ;
Mattot, V ;
Nuyens, D ;
Lutgens, E ;
Clotman, F ;
de Ruiter, MC ;
Gittenberger-de Groot, A ;
Poelmann, R ;
Lupu, F ;
Herbert, JM ;
Collen, D ;
Dejana, E .
CELL, 1999, 98 (02) :147-157
[5]   Correlation of dynamic contrast-enhanced MR imaging with histologic tumor grade: Comparison of macromolecular and small-molecular contrast media [J].
Daldrup, H ;
Shames, DM ;
Wendland, M ;
Okuhata, Y ;
Link, TM ;
Rosenau, W ;
Lu, Y ;
Brasch, RC .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1998, 171 (04) :941-949
[6]   Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice [J].
Drab, M ;
Verkade, P ;
Elger, M ;
Kasper, M ;
Lohn, M ;
Lauterbach, B ;
Menne, J ;
Lindschau, C ;
Mende, F ;
Luft, FC ;
Schedl, A ;
Haller, H ;
Kurzchalia, TV .
SCIENCE, 2001, 293 (5539) :2449-2452
[7]  
Dvorak HF, 1999, CURR TOP MICROBIOL, V237, P97
[8]  
DVORAK HF, 1979, JNCI-J NATL CANCER I, V62, P1459
[9]   REGULATION OF EXTRAVASCULAR COAGULATION BY MICROVASCULAR PERMEABILITY [J].
DVORAK, HF ;
SENGER, DR ;
DVORAK, AM ;
HARVEY, VS ;
MCDONAGH, J .
SCIENCE, 1985, 227 (4690) :1059-1061
[10]  
DVORAK HF, 1988, AM J PATHOL, V133, P95